Arrowhead Research | ARWR - Debt

Arrowhead Research reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Heron Therapeutics HRTX:US USD 149.23M 52K
Intercept Pharmaceuticals ICPT:US USD 332.67M 365K
IONIS PHARMACEUT IONS:US USD 1.19B 64.22M
Ligand Pharmaceuticals LGND:US USD 76.74M 92K
Moderna Inc MRNA:US USD 1.07B 73M
Novartis NOVN:VX USD 27.91B 530M
Opko Health OPK:US USD 213.5M 38.19M
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
Tg Therapeutics TGTX:US USD 71.13M 1.1M
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M
YTE INCY:US USD 33.26M 326K